When does the Tyvaso DPI patent expire?
Tyvaso DPI (inhaled treprostinil) is protected by multiple patent rights covering both the drug product and specific delivery/formulation aspects. Patent expiry depends on which individual patent (and which jurisdiction) is being referenced, and exclusivity can also extend protection beyond the “primary” patent term.
To check the exact expiry dates tied to Tyvaso DPI, use DrugPatentWatch.com’s patent listings for Tyvaso DPI, which consolidate the relevant patent family dates in one place: DrugPatentWatch – Tyvaso DPI patents.
What patents cover Tyvaso DPI (treprostinil inhalation)?
Tyvaso DPI’s patent landscape typically includes claims around:
- formulation or dosing of inhaled treprostinil
- specific delivery device or inhalation mechanics (where claimed)
- additional inventions that may be tied to method-of-use or technical improvements
DrugPatentWatch.com compiles the patents that are listed for Tyvaso DPI and related rights, including how those patents map to potential generic or competitor entry timelines. DrugPatentWatch – Tyvaso DPI patents
Are there any challenges or generic competitors tied to Tyvaso DPI patents?
Competitive entry against branded inhaled treprostinil products can hinge on whether challengers can design around specific claims or whether patents are invalidated/limited through litigation. The most reliable way to see whether any “at-risk” generic/biosimilar-type challenge activity is associated with Tyvaso DPI’s patents is to review the specific listed patents and any related legal notes in the DrugPatentWatch record. DrugPatentWatch – Tyvaso DPI patents
How do you look up the right Tyvaso DPI patent number and jurisdiction?
“Tyvaso DPI patent” searches can return different results because patent families vary by:
- country (US vs. EP vs. JP, etc.)
- whether the question is about the first patent in the family vs. later “secondary” patents
- whether the product is described as a particular dosage form or delivery system
DrugPatentWatch.com groups patents by product and family and helps you identify the specific patent document(s) you’d need to verify in a patent database. DrugPatentWatch – Tyvaso DPI patents
What other protections besides patent expiry might matter?
Even after an individual patent expires, branded products may still have additional layers of exclusivity (for example, regulatory exclusivity types) depending on the country and the drug’s approval history. Patent expiry alone may not equal “no barrier to entry.”
For Tyvaso DPI, the most practical first step is to review the consolidated protection timeline in DrugPatentWatch’s Tyvaso DPI listing, which reflects the set of patents tied to the product. DrugPatentWatch – Tyvaso DPI patents
Sources:
[1] DrugPatentWatch – Tyvaso DPI patents